Oxitec

28 articles with Oxitec

• Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology

  6/3/2019

  Oxitec Ltd., a UK-based biotechnology company specializing in developing novel, environmentally-sustainable pest management solutions, announced the successful completion of the first field trial in Brazil of its 2nd Generation Friendly™ Aedes aegypti technology.

• Oxitec Signs New Multi-year Development Agreement to Apply 2nd Generation Technology to Control Soybean Looper

  4/16/2019

  Oxitec to develop a safe, self-limiting insect capable of reducing pest populations and reversing insect resistance to biotech traits and chemistries

• Oxitec Transitioning Friendly™ Self-limiting Mosquitoes to 2nd Generation Technology Platform, Paving Way to New Scalability, Performance and Cost Breakthroughs

  11/28/2018

  Oxitec's 2nd generation technology will be used across mosquito and agricultural pest applications globally

• Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes

  10/18/2018

  Expanded collaboration with the Bill & Melinda Gates Foundation will leverage Oxitec's Friendly™ biological engineering platform to develop a self-limiting Anopheles stephensi strain to help combat malaria in India, Middle East and the Horn of Africa 

• Oxitec to Apply New Generation of Self-limiting Mosquito Technology to Malaria-spreading Mosquitoes

  6/19/2018

  Oxitec, Ltd. announced it is entering into a cooperative agreement with the Bill & Melinda Gates Foundation ("BMGF") to develop a new strain of Oxitec's self-limiting Friendly(TM) Mosquitoes to combat a mosquito species that spreads malaria in the Western Hemisphere.

• Transfer Of Regulatory Jurisdiction For Oxitec's Self-Limiting Friendly Aedes In The United States

  10/5/2017

• Oxitec To Build State-Of-The-Art Mosquito Egg Production Unit

  9/20/2017

• Oxitec Launching Friendly Aedes Project In Juiz De Fora, Brazil

  7/12/2017

• Oxitec's Friendly Aedes Mosquito Receives Positive Evaluation For European Standard In Relation To Human Health And The Environment

  7/6/2017

• Intrexon Appoints Dr. Mark Carnegie-Brown As CEO Of Oxitec

  5/19/2017

• Oxitec Opens Large Scale Mosquito Production Facility In Brazil

  10/26/2016

• FDA Publishes Final Finding Of No Significant Impact And Environmental Assessment On Oxitec's Self-Limiting Mosquito

  8/5/2016

• First Evidence That GM Mosquitoes Reduce Disease, Oxitec Reveals

  7/18/2016

• Dengue Fever Cases Drop 91% In Neighbourhood Of Piracicaba, Brazil, Where Oxitec's Friendly Aedes Were Released

  7/14/2016

• Oxitec CEO To Testify Before Congressional Committee On May 25th

  5/23/2016

• Grand Cayman Will Use Oxitec Solution To Suppress Wild Aedes Aegypti, The Dangerous Mosquito That Spreads Dengue, Zika And Chikungunya, In An Effort To Help Eliminate These Diseases

  5/5/2016

• WHO Issues Positive Recommendation For Oxitec's Self-Limiting Mosquito

  3/21/2016

• FDA Publishes Preliminary Finding Of No Significant Impact On Oxitec's Self-Limiting Mosquito

  3/14/2016

• Intrexon Scores Oxitec in $160 Million Stock-Cash Deal

  8/10/2015

• Oxitec 'Self-limiting Gene' Offers Hope For Controlling Invasive Moth Without Using Pesticides

  7/16/2015